First, the discovery of rare, high penetrance germ-line mutations of BRCA1 and BRCA2 identified a small subset of women with a very high life-time risk of breast and ovarian cancer.
FORBES: After 40 Years Of Research, What Do We Know About Preventing Breast Cancer?